Methyl p‐hydroxybenzoate (E‐218) a preservative for drugs and food is an activator of the ryanodine receptor Ca 2+ release channel

Haloperidol is a drug used in the management of several psychotic disorders and its use has been linked to Neuroleptic Malignant Syndrome. In the present study we have investigated the effect of a commercial preparation of haloperidol, Serenase, on skeletal muscle sarcoplasmic reticulum. Addition of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 2009-01, Vol.131 (2), p.335-341
Hauptverfasser: Cavagna, Dario, Zorzato, Francesco, Babini, Elena, Prestipino, Gianfranco, Treves, Susan
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Haloperidol is a drug used in the management of several psychotic disorders and its use has been linked to Neuroleptic Malignant Syndrome. In the present study we have investigated the effect of a commercial preparation of haloperidol, Serenase, on skeletal muscle sarcoplasmic reticulum. Addition of Serenase to isolated terminal cisternae caused a rapid release of calcium. We tested whether the active Ca 2+ ‐releasing substance was haloperidol or another compound present in the preparation. Our results show that methyl p‐hydroxybenzoate, one of the preservatives and a commonly used anti‐microbial agent (E‐218) is an activator of Ca 2+ release (E.C.50=2.0 m M ), mediated by a ruthenium red‐sensitive Ca 2+ release channel present in skeletal muscle terminal cisternae. British Journal of Pharmacology (2000) 131 , 335–341; doi: 10.1038/sj.bjp.0703571
ISSN:0007-1188
1476-5381
DOI:10.1038/sj.bjp.0703571